Strand Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
103
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$96.7M
- Investors
-
18
Strand Therapeutics General Information
Description
Provider of biotechnology services intended to create gene therapies powered by synthetic biology. The company's offerings include immunotherapies to produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.
Contact Information
Website
www.strandtx.comCorporate Office
- 20 Overland Street
- Suite A
- Boston, MA 02215
- United States
Corporate Office
- 20 Overland Street
- Suite A
- Boston, MA 02215
- United States
Strand Therapeutics Timeline
Strand Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC (Series A) | 28-Nov-2022 | $96.7M | Completed | Pre-Clinical Trials | ||
8. Grant | 17-May-2021 | Completed | Pre-Clinical Trials | |||
7. Grant | 15-May-2021 | Completed | Pre-Clinical Trials | |||
6. Debt - PPP | 12-Apr-2020 | Completed | Pre-Clinical Trials | |||
5. Seed Round | 04-Jun-2019 | Completed | Pre-Clinical Trials | |||
4. Accelerator/Incubator | 15-May-2019 | Completed | Pre-Clinical Trials | |||
3. Accelerator/Incubator | 19-Oct-2018 | Completed | Startup | |||
2. Grant | 13-Mar-2018 | $2K | Completed | Startup | ||
1. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup |
Strand Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-2 | ||||||||
Series A-1 | ||||||||
Series A | 7,257,044 | $0.000010 | $5.81 | $5.81 | 1x | $5.81 | 22.57% | |
Seed | 5,886,624 | $0.000010 | $1 | $1 | 1x | $1 | 18.31% |
Strand Therapeutics Comparisons
Industry
Financing
Details
Strand Therapeutics Competitors (63)
One of Strand Therapeutics’s 63 competitors is Carisma Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
WaVe Life Sciences | Formerly VC-backed | Cambridge, MA | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Gadeta | Formerly VC-backed | Utrecht, Netherlands | ||||
CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland |
Strand Therapeutics Patents
Strand Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023262576-A1 | Lipid nanoparticles comprising venezuelan equine encephalitis (vee) replicon and uses thereof | Pending | 26-Apr-2022 | ||
CA-3225907-A1 | Polynucleotides and uses thereof | Pending | 03-Aug-2021 | ||
AU-2022323516-A1 | Polynucleotides and uses thereof | Pending | 03-Aug-2021 | ||
EP-4381080-A1 | Polynucleotides and uses thereof | Pending | 03-Aug-2021 | ||
US-20240360472-A1 | Polynucleotides and uses thereof | Pending | 03-Aug-2021 | C12N15/86 |
Strand Therapeutics Signals
Strand Therapeutics Investors (18)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
ATMA Capital | Venture Capital | Minority | ||
BeiGene | Corporation | Minority | ||
Camford Capital | Venture Capital | Minority | ||
DHVC | Venture Capital | Minority | ||
Eli Lilly and Company | Corporation | Minority |
Strand Therapeutics FAQs
-
When was Strand Therapeutics founded?
Strand Therapeutics was founded in 2017.
-
Where is Strand Therapeutics headquartered?
Strand Therapeutics is headquartered in Boston, MA.
-
What is the size of Strand Therapeutics?
Strand Therapeutics has 103 total employees.
-
What industry is Strand Therapeutics in?
Strand Therapeutics’s primary industry is Drug Discovery.
-
Is Strand Therapeutics a private or public company?
Strand Therapeutics is a Private company.
-
What is the current valuation of Strand Therapeutics?
The current valuation of Strand Therapeutics is
. -
What is Strand Therapeutics’s current revenue?
The current revenue for Strand Therapeutics is
. -
How much funding has Strand Therapeutics raised over time?
Strand Therapeutics has raised $103M.
-
Who are Strand Therapeutics’s investors?
ATMA Capital, BeiGene, Camford Capital, DHVC, and Eli Lilly and Company are 5 of 18 investors who have invested in Strand Therapeutics.
-
Who are Strand Therapeutics’s competitors?
Carisma Therapeutics, WaVe Life Sciences, NexImmune, Gadeta, and CRISPR Therapeutics are some of the 63 competitors of Strand Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »